Home › Funds › Invenomic Capital Management LP › ZBH

Invenomic Capital Management LP position in ZBH

ZIMMER BIOMET HOLDINGS INC · Health Care

Invenomic Capital Management LP reported holding 237,240 shares of ZBH (ZIMMER BIOMET HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$21.1M, representing 1.04% of its reported portfolio and ranking #37 among its reported holdings. Invenomic Capital Management LP has disclosed ZBH holdings in 5 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)237.24K sh
Reported value held$21.07M
Portfolio Weight1.04%
First reportedQ2 2025
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Invenomic Capital Management LP's ZBH position evolved

Invenomic Capital Management LP first disclosed a stake in ZBH in Q2 2025 at 89,088 shares (US$8.1M). The position peaked in Q3 2026 at 237,240 shares, worth US$21.1M. Across 5 filings, Invenomic Capital Management LP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 237,240 shares valued at US$21.1M — an increase of 58,549 shares quarter over quarter.. Notable position changes include a 27% increase in Q1 2026 (shares fell 5% over the following quarter), a 33% increase in Q3 2026 (shares rose 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 89.09K $8.13M New
Q4 2025 133.86K $12.04M New
Q1 2026 169.71K $15.34M Add
Q2 2026 178.69K $15.38M Add
Q3 2026 237.24K $21.07M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZBH and 13F data

ZBH (ZIMMER BIOMET HOLDINGS INC) is a Health Care company. 18 other funds we track also report a position in ZBH — the largest reported positions include Dodge & Cox (US$2.08B), DODGE & COX (US$2.02B), Harris Associates (Oakmark) (US$1.10B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZBH

All ZBH fund holders →

FAQ

How long has Invenomic Capital Management LP held ZBH?

Invenomic Capital Management LP has disclosed ZBH holdings in 5 of the last 6 reported quarters, going back to Q2 2025.

What is Invenomic Capital Management LP's current position in ZBH?

As of Q3 2026, Invenomic Capital Management LP holds 237.24K shares of ZBH (ZIMMER BIOMET HOLDINGS INC), valued at $21.07M, representing 1.04% of its reported portfolio and ranking #37.

Has Invenomic Capital Management LP been buying or selling ZBH?

In the latest 13F filing (Q3 2026), Invenomic Capital Management LP increased its position in ZBH. The position peaked in Q3 2026 at 237.24K shares.

Which other funds hold ZBH?

Other major institutional holders of ZBH include Dodge & Cox, DODGE & COX, Harris Associates (Oakmark), among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.